Wird geladen...
Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Genetic studies of patients with neonatal progeroid syndrome led to the discovery of the novel fasting-induced, glucogenic, and orexigenic hormone named asprosin, the C-terminal cleavage product of profibrillin. Upon secretion, asprosin travels to the liver, where it exerts a glucogenic effect throu...
Gespeichert in:
| Veröffentlicht in: | Diabetes |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Diabetes Association
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085243/ https://ncbi.nlm.nih.gov/pubmed/32198197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dbi19-0009 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|